Telegraph Hill Partners (THP), a venture capital and growth equity firm dedicated to building life science and healthcare technology businesses, has closed THP V, a new $525 million investment fund.
The fund will make investments in innovative companies that are commercialszing advanced technologies in areas including life science tools, reagents, specialty chemistries, medical technology, medical devices, diagnostics, healthcare IT, healthcare services, agriculture and animal health.
Consistent with its previous funds, THP V will invest in innovative companies across the lifecycle from startup to fully scaled. Investments will be structured to effectively address the capital needs of each company and its founders, and will include startup and growth capital, existing shareholder liquidity events, acquisitions/buyouts and corporate divestitures.
Read more: Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.